Osteoporosis: From Molecular Mechanisms to Therapies 2.0
Osteoporosis is a common skeletal disorder, occurring as a result of an imbalance between bone resorption and bone formation, with bone breakdown exceeding bone building. Bone resorption inhibitors, e.g., bisphosphonates, have been designed to treat osteoporosis. Teriparatide, an anabolic agent, sti...
Main Author: | Chih-Hsin Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/21/8005 |
Similar Items
-
Osteoporosis: From Molecular Mechanisms to Therapies 3.0
by: Chih-Hsin Tang
Published: (2021-11-01) -
Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0
by: Chih-Hsin Tang
Published: (2020-10-01) -
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
by: Ji-Yoon Noh, et al.
Published: (2020-10-01) -
The role of wnt signaling in diabetes-induced osteoporosis
by: Kairan Bao, et al.
Published: (2023-04-01) -
Mechanistic advances in osteoporosis and anti‐osteoporosis therapies
by: Haiwei Wang, et al.
Published: (2023-06-01)